[e-drug] Adverse effects of mefloquine: due to primary liver damage?

[andrew Herxheimer <Andrew_Herxheimer@compuserve.com>]

E-drug: Adverse effects of mefloquine: due to primary liver damage?
---------------------------------------------

Ashley Croft and I have just published a paper in BMC Public Health
(a freely accessible electronic journal), in which we suggest the
hypothesis that many of the adverse effects of mefloquine are due to
modest liver damage, possibly with secondary thyroid involvement.
The hypothesis needs testing, and meanwhile it seems advisable to
revise the contra-indications and warnings for the use of mefloquine.

The URL is http://www.biomedcentral.com/1471-2458/2/6

Andrew Herxheimer
Emeritus Fellow, UK Cochrane Centre
9 Park Crescent, London N3 2NL    UK
Phone  : +44 20 8346 5470    Fax  : +44 20 8346 0407
e-mail:  andrew_herxheimer@compuserve.com
--
To send a message to E-Drug, write to: e-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@usa.healthnet.org
Information and archives: http://www.healthnet.org/programs/edrug.html